Overview

Gender

female

Lynne has twenty years of experience in providing clinical operations and regulatory strategic planning for 10+ INDs and 1 NDA, and has coordinated large (+100) multicenter and multinational Phase 1 through Phase 3 clinical trials across multiple therapeutic areas (endocrinology, cardiovascular, antiviral, oncology and neurology) at companies such as Centocor, Sanofi and ViroPharma.

In addition she has held several key leadership roles as vice president clinical operations, regulatory affairs and quality assurance, most notably at BioRexis Pharmaceutical where she played a key role in facilitating the acquisition of BioRexis by Pfizer in 2007.

Lynne received her Bachelor of Science degree from Russell Sage College, New York and is certified in regulatory affairs by the Regulatory Affairs Professionals Society.